Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Clinical trial NCT00532454 · TERMINATED

Trial details

NCT number: NCT00532454
Sponsor: National Cancer Center, Korea
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Disease

Start date: 2006-06-01
Primary completion: 2006-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.